Skip to main content
. 2016 Sep;22(9):10.18553/jmcp.2016.22.9.1088. doi: 10.18553/jmcp.2016.22.9.1088

TABLE 7.

Results of TNF-IR Combination Therapy

1 Year 2 Years
Tofa + MTX ADA + MTX Tofa + MTX ADA + MTX
Total cost $25,227,134 $30,319,508 $53,022,456 $61,633,990
Cost PMPM $2.10 $2.53 $2.21 $2.57
ACR20 responders 363 352 400 392
Cost per ACR20 responder $69,575 $86,164 $132,500 $157,273

Note: For TNF-IR results, all therapies were administered as combination therapy with MTX. The analysis is based on 528 treated patients. The cost PMPM is based on the total number of 1 million organization (plan) members.

ACR = American College of Rheumatology; ADA = adalimumab; MTX = methotrexate; PMPM = per member per month; TNF-IR = tumor necrosis factor inhibitor inadequate responder; Tofa = tofacitinib.